Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer

1. Van Gils MJ, Sanders RW (2013) Broadly neutralizing antibodies against HIV-1: templates for a vaccine. Virology 435 : 46–56. doi: 10.1016/j.virol.2012.10.004 23217615

2. Barouch DH, Whitney JB, Moldt B, Klein F, Oliveira TY, et al. (2013) Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature 503 : 224–228. doi: 10.1038/nature12744 24172905

3. Van den Kerkhof TLGM, Euler Z, van Gils MJ, Boeser-Nunnink BD, Schuitemaker H, et al. (2014) Early development of broadly reactive HIV-1 neutralizing activity in elite neutralizers. AIDS 28 : 1237–1240. doi: 10.1097/QAD.0000000000000228 24556870

4. Doria-Rose N a, Schramm C a, Gorman J, Moore PL, Bhiman JN, et al. (2014) Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature 509 : 55–62. doi: 10.1038/nature13036 24590074

5. Blattner C, Lee JH, Sliepen K, Derking R, Falkowska E, et al. (2014) Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers. Immunity 40 : 669–680. doi: 10.1016/j.immuni.2014.04.008 24768348

6. Falkowska E, Le KM, Ramos A, Doores KJ, Lee JH, et al. (2014) Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers. Immunity 40 : 657–668. doi: 10.1016/j.immuni.2014.04.009 24768347

7. West AP, Scharf L, Horwitz J, Klein F, Nussenzweig MC, et al. (2013) Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues. Proc Natl Acad Sci U S A 110 : 10598–10603. doi: 10.1073/pnas.1309215110 23754383

8. Huang J, Kang BH, Pancera M, Lee JH, Tong T, et al. (2014) Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface. Nature 515 : 138–142. doi: 10.1038/nature13601 25186731

9. Ringe RP, Sanders RW, Yasmeen A, Kim HJ, Lee JH, et al. (2013) Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation. Proc Natl Acad Sci U S A 110 : 18256–18261. doi: 10.1073/pnas.1314351110 24145402

10. Klein F, Gaebler C, Mouquet H, Sather DN, Lehmann C, et al. (2012) Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein. J Exp Med 209 : 1469–1479. doi: 10.1084/jem.20120423 22826297

11. Lee JH et al. (2014) Pre-fusion gp41 conformational epitope antibodies neutralize HIV-1 by inducing viral spike decay. Submitted.

12. Sanders RW, Derking R, Cupo A, Julien J-P, Yasmeen A, et al. (2013) A next-generation cleaved, soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog 9: e1003618. doi: 10.1371/journal.ppat.1003618 24068931

13. Moore JP, Sodroski J (1996) Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J Virol 70 : 1863–1872. 8627711

14. Julien J, Lee JH, Cupo A, Murin CD, Derking R, et al. (2013) Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9. Proc Natl Acad Sci U S A 110 : 4351–4356. doi: 10.1073/pnas.1217537110 23426631

15. Binley JM, Sanders RW, Clas B, Schuelke N, Master a, et al. (2000) A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J Virol 74 : 627–643. 10623724

16. Sanders RW, Vesanen M, Schuelke N, Master A, Schiffner L, et al. (2002) Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J Virol 76 : 8875–8889. 12163607

17. Julien J-P, Sok D, Khayat R, Lee JH, Doores KJ, et al. (2013) Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans. PLoS Pathog 9: e1003342. doi: 10.1371/journal.ppat.1003342 23658524

18. Julien J-P, Cupo A, Sok D, Stanfield RL, Lyumkis D, et al. (2013) Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science 342 : 1477–1483. doi: 10.1126/science.1245625 24179159

19. Lyumkis D, Julien J-P, de Val N, Cupo A, Potter CS, et al. (2013) Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science 342 : 1484–1490. doi: 10.1126/science.1245627 24179160

20. Kong L, Lee JH, Doores KJ, Murin CD, Julien J-P, et al. (2013) Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat Struct Mol Biol 20 : 796–803. doi: 10.1038/nsmb.2594 23708606

21. Pancera M, Zhou T, Druz A, Georgiev IS, Soto C, et al. (2014) Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature 514 : 455–461. doi: 10.1038/nature13808 25296255

22. Sanders RW, Moore JP (2014) HIV: A stamp on the envelope. Nature 514 : 437–438. doi: 10.1038/nature13926 25296251

23. Klasse PJ, Depetris RS, Pejchal R, Julien J-P, Khayat R, et al. (2013) Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein. J Virol 87 : 9873–9885. doi: 10.1128/JVI.01226-13 23824824

24. Khayat R, Lee JH, Julien J-P, Cupo A, Klasse PJ, et al. (2013) Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers. J Virol 87 : 9865–9872. doi: 10.1128/JVI.01222-13 23824817

25. Pejchal R, Doores KJ, Walker LM, Khayat R, Huang P-S, et al. (2011) A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 334 : 1097–1103. doi: 10.1126/science.1213256 21998254

26. Scheid JF, Mouquet H, Ueberheide B, Diskin R, Klein F, et al. (2011) Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333 : 1633–1637. doi: 10.1126/science.1207227 21764753

27. Munro JB, Gorman J, Ma X, Zhou Z, Arthos J, et al. (2014) Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions. Science 346 : 759–763. doi: 10.1126/science.1254426 25298114

28. Guttman M, Cupo A, Julien J-P, Sanders RW, Wilson I a, et al. (2015) Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env. Nat Commun 6 : 6144. doi: 10.1038/ncomms7144 25652336

29. Hoffenberg S, Powell R, Carpov A, Wagner D, Wilson A, et al. (2013) Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes. J Virol 87 : 5372–5383. doi: 10.1128/JVI.02827-12 23468492

30. White T a, Bartesaghi A, Borgnia MJ, de la Cruz MJ V, Nandwani R, et al. (2011) Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography. J Virol 85 : 12114–12123. doi: 10.1128/JVI.05297-11 21937655

31. Walker LM, Huber M, Doores KJ, Falkowska E, Pejchal R, et al. (2011) Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477 : 466–470. doi: 10.1038/nature10373 21849977

32. Li Y, O’Dell S, Walker LM, Wu X, Guenaga J, et al. (2011) Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01. J Virol 85 : 8954–8967. doi: 10.1128/JVI.00754-11 21715490

33. Tran EEH, Borgnia MJ, Kuybeda O, Schauder DM, Bartesaghi A, et al. (2012) Structural mechanism of trimeric HIV-1 envelope glycoprotein activation. PLoS Pathog 8: e1002797. doi: 10.1371/journal.ppat.1002797 22807678

34. Thali M, Moore JP, Furman C, Charles M, Ho DD, et al. (1993) Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol 67 : 3978–3988. 7685405

35. Yasmeen A, Ringe R, Derking R, Cupo A, Julien J-P, et al. (2014) Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits. Retrovirology 11 : 41. doi: 10.1186/1742-4690-11-41 24884783

36. Scharf L, Scheid JF, Lee JH, West AP, Chen C, et al. (2014) Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike. Cell Rep 7 : 785–795. doi: 10.1016/j.celrep.2014.04.001 24767986

37. Zhou T, Georgiev I, Wu X, Yang Z-Y, Dai K, et al. (2010) Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 329 : 811–817. doi: 10.1126/science.1192819 20616231

38. Balla-Jhagjhoorsingh SS, Corti D, Heyndrickx L, Willems E, Vereecken K, et al. (2013) The N276 glycosylation site is required for HIV-1 neutralization by the CD4 binding site specific HJ16 monoclonal antibody. PLoS One 8: e68863. doi: 10.1371/journal.pone.0068863 23874792

39. McGuire AT, Hoot S, Dreyer AM, Lippy A, Stuart A, et al. (2013) Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies. J Exp Med 210 : 655–663. doi: 10.1084/jem.20122824 23530120

40. Burton DR, Pyati J, Koduri R, Sharp SJ, Thornton GB, et al. (1994) Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266 : 1024–1027. 7973652

41. Trkola A, Pomales AB, Yuan H, Korber B, Maddon PJ, et al. (1995) Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virol 69 : 6609–6617. 7474069

42. Muster T, Steindl F, Purtscher M, Trkola a, Klima a, et al. (1993) A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 67 : 6642–6647. 7692082

43. Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, et al. (2001) Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol 75 : 10892–10905. 11602729

44. Wibmer CK, Bhiman JN, Gray ES, Tumba N, Abdool Karim SS, et al. (2013) Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes. PLoS Pathog 9: e1003738. doi: 10.1371/journal.ppat.1003738 24204277

45. Gao F, Bonsignori M, Liao H-X, Kumar A, Xia S-M, et al. (2014) Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies. Cell 158 : 481–491. doi: 10.1016/j.cell.2014.06.022 25065977

46. Carrillo J. et al (n.d.) Gp120/CD4 Blocking Antibodies are Frequently Elicited in ART-naïve Chronically HIV-1 Infected Individuals. Submitted.

47. Voss NR, Yoshioka CK, Radermacher M, Potter CS, Carragher B (2009) DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy. J Struct Biol 166 : 205–213. 19374019

48. Ogura T, Iwasaki K, Sato C (2003) Topology representing network enables highly accurate classification of protein images taken by cryo electron-microscope without masking. J Struct Biol 143 : 185–200. 14572474

49. Lander GC, Stagg SM, Voss NR, Cheng A, Fellmann D, et al. (2009) Appion: an integrated, database-driven pipeline to facilitate EM image processing. J Struct Biol 166 : 95–102. 19263523

50. Tang G, Peng L, Baldwin PR, Mann DS, Jiang W, et al. (2007) EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol 157 : 38–46. 16859925

51. Ludtke SJ, Baldwin PR, Chiu W (1999) EMAN: semiautomated software for high-resolution single-particle reconstructions. J Struct Biol 128 : 82–97. 10600563

52. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25 : 1605–1612. 15264254